DR Horton Is Maintained at Neutral by Citigroup
D.R. Horton Analyst Ratings
Citi Maintains D.R. Horton(DHI.US) With Hold Rating, Cuts Target Price to $152
DR Horton Is Maintained at Overweight by Wells Fargo
D.R. Horton Analyst Ratings
Wells Fargo Maintains D.R. Horton(DHI.US) With Buy Rating, Cuts Target Price to $175
Argus Adjusts Price Target on D.R. Horton to $190 From $200
Evercore Maintains D.R. Horton(DHI.US) With Buy Rating, Raises Target Price to $212
DR Horton (DHI) Gets a Buy From Evercore ISI
BofA Securities Maintains D.R. Horton(DHI.US) With Buy Rating, Announces Target Price $290
D.R. Horton Upgraded to Buy From Neutral at BofA
JP Morgan Downgrades D.R. Horton to Underweight, Lowers Price Target to $156
D.R. Horton Analyst Ratings
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Barclays Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $170
KBW Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $183
D.R. Horton Downgraded to Market Perform From Outperform at Keefe Bruyette
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating
Seaport Global Maintains D.R. Horton(DHI.US) With Hold Rating